Drugs that lack single-agent activity: Are they worth pursuing in combination?

Bishal Gyawali, Vinay Prasad

Research output: Contribution to journalComment/debate

8 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)193-194
Number of pages2
JournalNature Reviews Clinical Oncology
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology

Cite this

Drugs that lack single-agent activity : Are they worth pursuing in combination? / Gyawali, Bishal; Prasad, Vinay.

In: Nature Reviews Clinical Oncology, Vol. 14, No. 4, 01.04.2017, p. 193-194.

Research output: Contribution to journalComment/debate

@article{4e480c5d63bb4a3785c6c702e3411cf4,
title = "Drugs that lack single-agent activity: Are they worth pursuing in combination?",
author = "Bishal Gyawali and Vinay Prasad",
year = "2017",
month = "4",
day = "1",
doi = "10.1038/nrclinonc.2017.27",
language = "English (US)",
volume = "14",
pages = "193--194",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Drugs that lack single-agent activity

T2 - Are they worth pursuing in combination?

AU - Gyawali, Bishal

AU - Prasad, Vinay

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85014548814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014548814&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2017.27

DO - 10.1038/nrclinonc.2017.27

M3 - Comment/debate

C2 - 28266519

AN - SCOPUS:85014548814

VL - 14

SP - 193

EP - 194

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 4

ER -